This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Fate Therapeutics, Inc.. Active years: 2016-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2021
Title: Dan Shoemaker: Innovator in Ischemia Treatment
Introduction
Dan Shoemaker is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of medical treatments, particularly in the area of ischemia. With a total of 3 patents to his name, Shoemaker's work focuses on enhancing therapeutic properties of stem and progenitor cells.
Latest Patents
One of his latest patents involves methods of treating ischemia. This invention provides compositions comprising stem and/or progenitor cells that have been treated to enhance their therapeutic properties for treating ischemia. The invention specifically relates to the use of these enhanced cells to treat ischemic tissue, tissue damaged by ischemia, or symptoms associated with such conditions.
Career Highlights
Dan Shoemaker is currently associated with Fate Therapeutics, Inc., where he continues to innovate in the field of regenerative medicine. His work has the potential to significantly impact the treatment of ischemic conditions, offering new hope for patients suffering from related ailments.
Collaborations
Shoemaker has collaborated with notable colleagues, including David Robbins and John D Mendlein, further enhancing the scope and impact of his research.
Conclusion
Dan Shoemaker's innovative work in the treatment of ischemia showcases his dedication to advancing medical science. His contributions through patents and collaborations highlight the importance of research in improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile